Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 405
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Reliability of the Shared Decision Making Process Survey

Completed
Has Results
  • High Cholesterol
  • +4 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    May 19, 2022

    Breast Cancer Trial in Boston, Ann Arbor (drug, procedure, radiation)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Boston, Massachusetts
    • +2 more
    May 2, 2022

    Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Aurora, Colorado
    • +132 more
    Apr 26, 2022

    Oral Cancer Directed Therapy, Breast Cancer, Gastrointestinal Cancer Trial in Boston (Active Care Team Alert, Passive Care Team

    Completed
    • Oral Cancer Directed Therapy
    • +3 more
    • Active Care Team Alert
    • Passive Care Team Alert
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    May 11, 2022

    Breast Cancer Trial in Boston (Eribulin Mesylate, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Boston, Massachusetts
    • +2 more
    Apr 18, 2022

    Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)

    Active, not recruiting
    • Breast Cancer
    • Amcenestrant-matching placebo
    • +5 more
    • Daphne, Alabama
    • +299 more
    May 5, 2022

    Hypertension, Diabetes, Breast Cancer Trial in Boston (Equity Dashboard and Community Health Worker Support, Equity Dashboard

    Recruiting
    • Hypertension
    • +2 more
    • Equity Dashboard and Community Health Worker Support
    • Equity Dashboard and Population Health Coordinator Support
    • Boston, Massachusetts
      Massachusetts General Hospital
    May 3, 2022

    Breast Cancer Trial in Boston, Cambridge (Sapacitabine, Olaparib)

    Active, not recruiting
    • Breast Cancer
    • Boston, Massachusetts
    • +1 more
    May 2, 2022

    Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

    Recruiting
    • Small Cell Lung Cancer
    • +4 more
    • PF-07104091 monotherapy dose escalation
    • +8 more
    • Clive, Iowa
    • +22 more
    Apr 26, 2022

    Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Trastuzumab deruxtecan (T-DXd)
    • Ado-trastuzumab emtansine (T-DM1)
    • Los Angeles, California
    • +163 more
    Apr 1, 2022

    Breast Cancer, Triple Negative Breast Cancer Trial in Washington, Boston, Chapel Hill (Niraparib, Dostarlimab, Radiation

    Recruiting
    • Breast Cancer
    • Triple Negative Breast Cancer
    • Washington, District of Columbia
    • +2 more
    Apr 13, 2022

    Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Mobile, Alabama
    • +437 more
    Mar 21, 2022

    Prosigna Assay on Neoadjuvant Clinical Decision-making in

    Recruiting
    • Breast Cancer
    • Prosigna PAM-50 assay
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Apr 5, 2022

    Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)

    Active, not recruiting
    • Breast Cancer
    • Renal Cell Carcinoma
    • IPI-549 (eganelisib)
    • +3 more
    • Chandler, Arizona
    • +23 more
    Apr 1, 2022

    Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)

    Completed
    Has Results
    • Breast Cancer
    • Autologous, Lethally Irradiated Breast Cancer Cells
    • Boston, Massachusetts
    • +1 more
    Mar 30, 2022

    Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)

    Completed
    Has Results
    • Breast Cancer
    • Autologous, Lethally Irradiated Breast Cancer Cells
    • Boston, Massachusetts
    • +1 more
    Mar 30, 2022

    Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

    Completed
    • Colorectal Cancer (CRC)
    • +10 more
    • San Francisco, California
    • +16 more
    Mar 30, 2022

    Solid Tumors, Colorectal Cancer, Breast Cancer Trial in Canada, United States (LY2880070, Gemcitabine)

    Completed
    • Solid Tumors
    • +11 more
    • Boston, Massachusetts
    • +8 more
    Mar 18, 2022

    Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer Trial in Boston (Breast Cancer Treatment

    Completed
    • Breast Cancer
    • +3 more
    • Breast Cancer Treatment Decision Aid for women 70+
    • Usual Care
    • Boston, Massachusetts
    • +1 more
    Mar 10, 2022

    Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Birmingham, Alabama
    • +84 more
    Mar 15, 2022

    Breast Cancer Trial in United States (Palbociclib, Aromatase Inhibitor)

    Completed
    Has Results
    • Breast Cancer
    • San Francisco, California
    • +9 more
    Mar 18, 2022

    Breast Cancer Trial in United States (Carboplatin, Nivolumab)

    Active, not recruiting
    • Breast Cancer
    • Stamford, Connecticut
    • +9 more
    Mar 21, 2022

    Breast Cancer Trial in United States (Neratinib, Fulvestrant)

    Active, not recruiting
    • Breast Cancer
    • Indianapolis, Indiana
    • +5 more
    Mar 2, 2022

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer Trial in Boston, Nashville (T-DM1, Pertuzumab, Excision of

    Active, not recruiting
    Has Results
    • HER-2 Positive Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +3 more
    Mar 4, 2022